AT1 — Atomo Diagnostics Cashflow Statement
0.000.00%
- AU$12.63m
- AU$9.30m
- AU$5.33m
Annual cashflow statement for Atomo Diagnostics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 0.005 | 0.074 | 0.913 | 1.89 | 1.61 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -2.81 | -5.85 | -4.69 | -1.96 | -3.37 |
| Capital Expenditures | -2.31 | -0.401 | -0.016 | -0.034 | -0.035 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Cash from Investing Activities | -2.31 | -0.401 | -0.016 | -0.034 | -0.035 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.018 | -0.171 | 1.87 | 1.46 | 3.81 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -4.98 | -6.5 | -2.78 | -0.468 | 0.489 |